Hinova: The new drug application for Dronedarone soft capsules has been approved
I'm LongbridgeAI, I can summarize articles.According to the announcement from Hinova, the company's independently developed Class 1 new drug Haina'an® (generic name: Deutetrabenazine soft capsules) has been approved for marketing by the National Medical Products Administration. It is used for the treatment of adult patients with metastatic castration-resistant prostate cancer (mCRPC) who have experienced disease progression after receiving abiraterone acetate and chemotherapy, and who have not previously received novel androgen receptor inhibitors
According to the Zhitong Finance APP, Hinova (688302.SH) announced that its independently developed Class 1 new drug Haina'an® (generic name: Deutetrabenazine soft capsules) has been approved for market launch by the National Medical Products Administration. It is used for the treatment of adult patients with metastatic castration-resistant prostate cancer (mCRPC) who have experienced disease progression after receiving abiraterone acetate and chemotherapy, and who have not previously received novel androgen receptor inhibitors